Etana Biopharmaceutical Indonesia

Etana Biopharmaceutical is an Indonesian biopharmaceutical company focused on developing and manufacturing high-quality, affordable biological therapies for the Southeast Asian market. The company specializes in oncology, hematology, and infectious diseases, notably establishing the first mRNA manufacturing facility in the region. Etana's portfolio includes biosimilars such as bevacizumab and erythropoietin, as well as innovative mRNA vaccines developed through strategic international partnerships. By leveraging local manufacturing capabilities and global technology transfers, Etana aims to improve patient access to life-saving treatments in emerging markets. The company operates a state-of-the-art production facility in Jakarta that adheres to international GMP standards. Their strategic collaborations with global biotech leaders allow them to bring advanced medical technologies to Indonesia and the broader ASEAN region.